These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15536604)

  • 21. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.
    Pistrosch F; Herbrig K; Kindel B; Passauer J; Fischer S; Gross P
    Diabetes; 2005 Jul; 54(7):2206-11. PubMed ID: 15983223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
    Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
    Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model.
    Tomino Y; Tanimoto M; Shike T; Shiina K; Fan Q; Liao J; Gohda T; Makita Y; Funabiki K
    Curr Diabetes Rev; 2005 Aug; 1(3):281-6. PubMed ID: 18220604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
    Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
    Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
    Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
    Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats.
    Koshinaka K; Oshida Y; Han YQ; Ohsawa I; Sato Y
    Metabolism; 2004 Jan; 53(1):22-7. PubMed ID: 14681837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):324-33. PubMed ID: 22261714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta mice.
    Aoki T; Kaneko S; Tanimoto M; Gohda T; Hagiwara S; Murakoshi M; Ishikawa Y; Furukawa M; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(1):127-36. PubMed ID: 21725918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
    Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
    J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.
    Shike T; Gohda T; Tanimoto M; Kobayashi M; Makita Y; Funabiki K; Horikoshi S; Hirose S; Shirai T; Tomino Y
    Nephrol Dial Transplant; 2005 May; 20(5):879-85. PubMed ID: 15769825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymosin β4 attenuates early diabetic nephropathy in a mouse model of type 2 diabetes mellitus.
    Zhu J; Su LP; Zhou Y; Ye L; Lee KO; Ma JH
    Am J Ther; 2015; 22(2):141-6. PubMed ID: 23846524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosiglitazone reduces urinary albumin excretion in type II diabetes.
    Bakris G; Viberti G; Weston WM; Heise M; Porter LE; Freed MI
    J Hum Hypertens; 2003 Jan; 17(1):7-12. PubMed ID: 12571611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice.
    Lee JO; Auger C; Park DH; Kang M; Oak MH; Kim KR; Schini-Kerth VB
    PLoS One; 2013; 8(6):e65227. PubMed ID: 23755196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.